UROTHELIAL CANCER

Clinical trials for UROTHELIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new UROTHELIAL CANCER trials appear

Sign up with your email to follow new studies for UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 5 Not yet finished but already full! 12 Completed 4 Terminated 1

First human test of Pfizer's new cancer drug halted early

Disease control Terminated

This was an early-stage study to test the safety and find the right dose of a new cancer drug called PF-07265028. It was given alone and in combination with another immunotherapy drug, sasanlimab, to a small group of people with advanced solid tumors that had stopped responding t…

Matched conditions: UROTHELIAL CANCER

Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

UROTHELIAL CANCER

Get alerted when new UROTHELIAL CANCER trials appear

First human test of Pfizer's new cancer drug halted early